Short answer: Chemical testing can identify compounds present in vaping liquids and aerosols, compare product types, and generate plausible exposure hypotheses. It does not, by itself, establish which compound caused a particular person’s lung injury.
Muthumalage and colleagues examined chemical constituents in e-cigarette or vaping products associated with the EVALI outbreak. The researchers compared counterfeit THC-containing cartridges with medical-grade and cannabidiol-containing products. Their analytical approach included gas chromatography–mass spectrometry for organic compounds and inductively coupled plasma mass spectrometry for elemental metals.
This design matters because “a THC vape” is not a single chemical exposure. A cartridge may contain cannabinoids, diluents, terpenes, residual solvents, pesticides, plasticizers, metals released from hardware, or thermal breakdown products. An analytical screen can separate that complex mixture into testable components.
The study reported vitamin E acetate and THC in counterfeit cartridges, along with additional potential toxicants. These included solvent-derived hydrocarbons, silicon-containing compounds, terpenes, pesticide or plasticizer-related compounds, polycaprolactones, and metals. The authors noted that several detected chemical classes have toxicological relevance to respiratory symptoms reported in EVALI cases.
The important forensic point is that co-detection creates competing and potentially interacting exposure hypotheses. Finding vitamin E acetate does not erase the presence of other constituents. Likewise, finding several chemicals does not show that each contributed equally—or at all—to an individual injury.
An instrument can establish that a compound was detected in the tested material. It may also quantify the compound if the method, calibration, matrix controls, and reporting limits support quantitation. Causation requires more: the person’s actual product, frequency and manner of use, aerosol-generation conditions, dose, timing, clinical findings, competing diagnoses, and sometimes biological testing.
A cartridge’s liquid composition also is not automatically identical to the aerosol reaching the lung. Heating can change chemical composition, and device temperature, coil condition, voltage, and user behavior can influence what is generated. The study’s comparison of liquid and vapor phases therefore addresses a key exposure-reconstruction problem.
The paper does not provide a universal chemical profile for all illicit or commercial cartridges. It does not convert a chemical detected in a tested cartridge into proof that a specific patient inhaled a medically significant dose. It also does not isolate one constituent as the sole cause of every EVALI presentation.
For litigation or expert review, the strongest analysis keeps product chemistry, exposure reconstruction, and medical causation in separate evidentiary steps.
Muthumalage T, Friedman MR, McGraw MD, Friedman AE, Rahman I. Chemical constituents involved in e-cigarette, or vaping product use-associated lung injury (EVALI). PubMed record. Full-text preprint DOI.